【结 构 式】 |
【分子编号】10399 【品名】3-Ethoxy-4-(pentyloxy)benzoic acid 【CA登记号】 |
【 分 子 式 】C14H20O4 【 分 子 量 】252.3104 【元素组成】C 66.65% H 7.99% O 25.36% |
合成路线1
该中间体在本合成路线中的序号:(II)This compound can be obtained by three related ways: 1) The carboxylation of 3-ethoxy-4-pentyloxyiodobenzene (I) with CO2 and butyllithium in ether gives 3-ethoxy-4-pentyloxybenzoic acid (II), which is reduced with LiAlH4 in refluxing ether to yield the corresponding benzyl alcohol (III). The controlled oxidation of (III) with pyridinium chlorochromate in dichloromethane affords 3-ethoxy-4-pentyloxybenazldehyde (IV), which is treated wtih NaCN and acetic acid - water giving 2-(3-ethoxy-4-pentyloxyphenyl)-2-hydroxyacetonitrile (V). Finally, this compound is cyclized with thiourea (VI) and HCl in 2-methoxyethanol. 2) The alkylation of ethyl-vanilline (VII) with c and K2CO3 in hot DMF gives aldehyde (IV), which by reaction with NaCH in methanol - HCl yields the cyanohydrine (V). The reaction of (V) with SOCl2 in refluxing CHCl3 affords 2-chloro-2-(3-ethoxy-5-pentyloxyphenyl)acetonitrile (VIII), which is finally cyclized with thiourea (VI) in ethylene glycol monomethyl ether - HCl at 110 C in refluxing ethanol - HCl. 3) The cyclization of 2-(3-ethoxy-4-pentyloxyphenyl)-2-hydroxyacetic acid (IX) with thiourea (VI) under acidic conditions gives 5-(3-ethoxy-4-pentyloxyphenyl)-2-iminothiazolidin-4-one (X), which is then hydrolyzed to the desired product.
【1】 Awata, T.; Maenaka, T.; Kawamatsu, Y. (Senju Pharmaceuticals Co., Ltd.); Ophthalmic topical agent for remedy of diseases of iris and ciliary body. EP 0170237; JP 1986043114; US 4602026 . |
【2】 Kawamatsu, Y.; Yamamoto, Y. (Senju Pharmaceuticals Co., Ltd.; Takeda Chemical Industries, Ltd.); Thiazolidine derivs. and their production and use. EP 0033617 . |
【3】 Imanishi, M.; Imamiya, E.; Kawamatsu, Y.; Hayashi, N.; Synthesis of 5-(3-ethoxy-4-pentyloxyphenyl)-2,4-[5-14C]thiazolidinedione ([14C]CT-112). J Takeda Res Lab 1983, 42, 3/4, 238-40. |
【4】 Tawada, H.; Mizuno, K.; Meguro, K.; Sohda, T.; Imamiya, E.; Kawamatsu, Y.; Yamamoto, Y.; Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors. Chem Pharm Bull 1982, 30, 10, 3601-16. |
【5】 Prous, J.; Castaner, J.; CT-112. Drugs Fut 1991, 16, 10, 895. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10398 | 2-Ethoxy-4-iodo-1-(pentyloxy)benzene; 2-Ethoxy-4-iodophenyl pentyl ether | C13H19IO2 | 详情 | 详情 | |
(II) | 10399 | 3-Ethoxy-4-(pentyloxy)benzoic acid | C14H20O4 | 详情 | 详情 | |
(III) | 10400 | [3-Ethoxy-4-(pentyloxy)phenyl]methanol | C14H22O3 | 详情 | 详情 | |
(IV) | 10401 | 3-Ethoxy-4-(pentyloxy)benzaldehyde | C14H20O3 | 详情 | 详情 | |
(V) | 10402 | 2-[3-Ethoxy-4-(pentyloxy)phenyl]-2-hydroxyacetonitrile | C15H21NO3 | 详情 | 详情 | |
(VI) | 10180 | Thiourea | 62-56-6 | CH4N2S | 详情 | 详情 |
(VII) | 10404 | Ethyl vanillin; 3-Ethoxy-4-hydroxybenzaldehyde | 121-32-4 | C9H10O3 | 详情 | 详情 |
(VIII) | 10405 | 2-Chloro-2-[3-ethoxy-4-(pentyloxy)phenyl]acetonitrile | C15H20ClNO2 | 详情 | 详情 | |
(IX) | 10406 | 2-[3-Ethoxy-4-(pentyloxy)phenyl]-2-hydroxyacetic acid | C15H22O5 | 详情 | 详情 | |
(X) | 10407 | 5-[3-Ethoxy-4-(pentyloxy)phenyl]-2-imino-1,3-thiazolidin-4-one | C16H22N2O3S | 详情 | 详情 |